Abstract:BACKGROUND: The DYNC1H1 gene encodes a part of the dynamic protein, and the protein mutations may further affect the growth and development of neurons, resulting in degeneration of anterior horn cells of the spinal cord, and a variety of clinical phenotypes finally resulting in axonal Charcot-Marie-Tooth disease type 20 (CMT20), mental retardation 13 (MRD13) and spinal muscular atrophy with lower extremity predominant 1 (SMA-LED). The incidence of the disease is low, and it is difficult to diagnose, especially in children. Here, we report a case of DYNC1H1 gene mutation and review the related literature to improve the pediatrician's understanding of DYNC1H1 gene-related disease to make an early correct diagnosis and provide better services for children.CASE SUMMARY: A 4-mo-old Chinese female child with adducted thumbs, high arch feet, and epileptic seizure presented slow response, delayed development, and low limb muscle strength. Electroencephalogram showed abnormal waves, a large number of multifocal sharp waves, sharp slow waves, and multiple spasms with a series of attacks. High-throughput sequencing and Sanger sequencing identified a heterozygous mutation, c.5885G>A (p.R1962H), in the DYNC1H1 gene (NM_001376) of the proband, which was not identified in her parents. Combined with the clinical manifestations and pedigree of this family, this mutation is likely pathogenic based on the American Academy of Medical Genetics and Genomics guidelines. The child was followed when she was 1 year and 2 mo old. The magnetic resonance imaging result was consistent with the findings of white matter myelinated dysplasia and congenital giant gyrus. The extensive neurogenic damage to the extremities was considered, as the results of electromyography showed that the motor conduction velocity and sensory conduction of the nerves of the extremities were not abnormal, and the degree of fit of the children with severe contraction was poor. At present, the child is 80 cm in length and 9 kg in weight, with slender limbs and low muscle strength, and still does not raise her head. She cannot sit or speak. Speech, motor, and mental development was significantly delayed. There is still no effective treatment for this disease.CONCLUSION: We herein report a de novo variant of DYNC1H1 gene, c.5885G>A (p.R1962H), leading to overlapping phenotypes (seizure, general growth retardation, and muscle weakness) of CMT20, MRD13, and SMA-LED, but there is no effective treatment for such condition. Our case enriches the DYNC1H1 gene mutation spectrum and provides an important basis for clinical diagnosis and treatment and genetic counseling.

Mutations GBA et TMEM175 et dystonie généralisée : à propos d’un cas

Analysis of Clinical Phenotype and CGH1 Gene Mutations in a Family Affected with Dopa-Responsive Dystonia

Présentation d’une nouvelle mutation du gène SLC9A6 responsable d’un syndrome de Lennox-Gastaut isolé

Association of Amyotrophic Lateral Sclerosis and Dopa-responsive dystonia in a Tunisian patient

Missense mutation in DYNC1H1 gene caused psychomotor developmental delay and muscle weakness: A case report

Novel Missense Variant in the TMEM151A Gene Causing Paroxysmal Kinesigenic Dyskinesia: a Case Report with Literature Review

[Clinical and Genetic Analysis of Childhood-Onset Myoclonus Dystonia Syndrome Caused by SGCE Variants].

Les Myopathies Oculo-Pharyngo-distales : Des Nouvelles Maladies À Expansions De Répétitions CGG

Myoclonus dystonia plus syndrome due to a novel 7q21 microdeletion

SCA27B/FGF14 : une ataxie peut en cacher une autre

GBA mutations are associated with Rapid Eye Movement Sleep Behavior Disorder

TMEM240 mutations cause spinocerebellar ataxia 21 with mental retardation and severe cognitive impairment

Microstructure of the cerebellum and its afferent pathways underpins dystonia in myoclonus dystonia

Clinical and Molecular Genetic Evaluation of Patients with Primary Dystonia

Retard statural dans la dystrophie musculaire de Duchenne

Dystonic Tremor as Main Clinical Manifestation of SCA21

Mutations in the gene encoding ɛ-sarcoglycan cause myoclonus–dystonia syndrome

DMD Mutations in 576 Dystrophinopathy Families: A Step Forward in Genotype-Phenotype Correlations

Case report: Genotype and phenotype of <i>DYNC1H1</i>-related malformations of cortical development: a case report and literature review

Chorea-ballism as a dominant clinical manifestation in heteroplasmic mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome with A3251G mutation in mitochondrial genome: a case report

Clinical and genetic characteristics of dopamine-responsive dystonia in 3 children